PRESS RELEASE published on 10/04/2023 at 21:30, 2 years 11 months ago EQS-Adhoc: EHC convenes EGM to extend business combination deadline and publishes repurchase document relating to redemption of public shares and proposed amendment of Warrant T&C
PRESS RELEASE published on 09/27/2023 at 18:30, 2 years 11 months ago European Healthcare Acquisition & Growth Company B.V. publishes its half-year report 2023
PRESS RELEASE published on 09/20/2023 at 12:30, 2 years 11 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. announces intention to extend Business Combination Deadline, to offer redemption of Public Shares and to terminate all Public and Sponsor Warrants
PRESS RELEASE published on 08/07/2023 at 19:00, 3 years ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH terminate discussion on business combination
PRESS RELEASE published on 06/27/2023 at 12:55, 3 years 2 months ago General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions
PRESS RELEASE published on 06/26/2023 at 19:15, 3 years 2 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. removes shareholders’ votes on proposed business combination with Croma-Pharma GmbH from agenda of general meeting
PRESS RELEASE published on 06/23/2023 at 19:30, 3 years 2 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. received redemption notices with respect to EUR 185.85 million – minimum net cash condition is not yet fulfilled
PRESS RELEASE published on 06/21/2023 at 09:43, 3 years 2 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: Public disclosure of inside information
PRESS RELEASE published on 05/16/2023 at 23:15, 3 years 3 months ago European Healthcare Acquisition & Growth Company B.V convenes annual general meeting of shareholders and publishes shareholder circular relating to proposed business combination with Croma-Pharma GmbH
PRESS RELEASE published on 05/16/2023 at 00:45, 3 years 3 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH, agree on adjusted enterprise value of Croma, and Sponsors waive 20% sponsor shares and devalue 20% sponsor warrants
Published on 09/05/2026 at 04:05, 1 day 6 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 1 day 11 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 1 day 11 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 1 day 12 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 1 day 20 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/06/2026 at 10:25, 24 minutes ago Over 400 media professionals seek new drivers for Asia-Pacific growth
Published on 09/06/2026 at 10:00, 49 minutes ago Haier Showcases AI-Powered Smart Home Ecosystem at IFA 2026
Published on 09/06/2026 at 06:00, 4 hours 49 minutes ago CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026
Published on 09/06/2026 at 05:15, 5 hours 34 minutes ago Experience AI Companion in Everyday Life at Hisense IFA 2026
Published on 09/05/2026 at 22:20, 12 hours 29 minutes ago PITAKA Marks Its Next Chapter in Berlin With "Signals in the Wind," Unveiling New iPhone 18 Accessories
Published on 09/04/2026 at 18:57, 1 day 15 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 1 day 17 hours ago Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 16:00, 1 day 18 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 1 day 18 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
